Children and adolescents should be proactively evaluated and treated for obesity, according to new guidelines from the American Academy of Pediatrics around childhood obesity. The guidelines note that ...

The WHO recommended GLP-1s as a treatment for obesity alongside a healthy diet and regular exercise. Milles Team/Stocksy The World Health Organization (WHO) has recommended the use of GLP-1 ...

The Lancet obesity framework aims to improve risk assessment but risks delaying treatment and deepening health inequities, according to recent evaluations.

GLP-1 receptor agonists for obesity are effective over the long term when paired with lifestyle interventions, but global accessibility must be improved, the World Health Organization (WHO) concluded.

OPINION - Modern GLP-1 medicines are evidence-based therapies that help patients achieve meaningful, sustained weight loss and reduce the risk of heart disease, type 2 diabetes, stroke and orthopedic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Despite the prevalence of obesity in nearly 42% of US ...

Revised diagnostic framework may limit access to early treatment, widen healthcare dispari ...

The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line treatments for most cases of obesity. This is due to their higher efficacy ...

Credit: Getty Images The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease. Test your ...

Redefining obesity based not only on body mass index (BMI) but on whether excess body fat is causing measurable health ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the pharmacologic treatment of obesity and overweight in adults. Covered topics in ...